BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2016
View Archived Issues
Novogen presents TMP3 inhibitors
Read More
Tolero initiates first-in-human study of oral TP-0903 in patients with advanced solid tumors
Read More
MacroGenics and Synthon Biopharmaceuticals sign antibody-drug conjugate agreement
Read More
microRNA-103-1 shows promise as a biomarker of ischemic brain damage
Read More
Novel oligomerspecific scFv antibody shows promise in several animal models of amyloidosis
Read More
Salmonella meningitis is associated with monocyte infiltration in mouse models
Read More
Novel HIV-1-specific bNAb can achieves near pan-neutralization of HIV-1
Read More
Chinese scientists patent FGFR inhibitors
Read More
Idenix Pharmaceuticals and Southern Research Institute disclose nucleoside derivatives
Read More
FDA approves MACI to repair knee cartilage defects
Read More
Bristol-Myers Squibb selects CTLA-4 Probody candidate from collaboration with CytomX
Read More
Sage begins phase II trials of SAGE-217 in Parkinson's disease and essential tremor
Read More
European Commission approves Ferring's Rekovelle
Read More
Topline data from phase III PATENCY-1 study of investigational vonapanitase in patients with CKD
Read More
Wi2 and Orion announce strategic collaboration in oncology
Read More
Centrexion Therapeutics reports topline data from phase IIb study of CNTX-4975
Read More
AcelRx Pharmaceuticals submits NDA to FDA for ARX-04
Read More
Genticel ends HPV therapeutics program based on phase II trial results
Read More
FDA accepts Dimension Therapeutics' IND for DTX-301
Read More
BioDelivery Sciences discontinues clonidine topical gel
Read More
Topline results from phase III trial of istradefylline in Parkinson's disease
Read More
Johnson & Johnson ends transaction discussions with Actelion
Read More
First clinical data for DCC-2618
Read More
Data reported from phase I study of first-in-class antisense oligonucleotide targeting AR
Read More
Phase I study of sEphB4-HSA in advanced solid tumors
Read More
First phase I data for of ravoxertinib in advanced solid tumors
Read More
Ab Initio Biotherapeutics and Pfizer enter GPCR collaboration
Read More
Spotlight Innovation obtains rights to compounds for Zika virus infection
Read More
First-in-human data for AstraZeneca's ATR inhibitor AZD-6738
Read More
EMA grants UGT1A1 gene therapy orphan designation for Crigler-Najjar syndrome
Read More